173 related articles for article (PubMed ID: 31422386)
21. Kidney-derived mesenchymal stromal cells modulate dendritic cell function to suppress alloimmune responses and delay allograft rejection.
Huang Y; Chen P; Zhang CB; Ko GJ; Ruiz M; Fiorina P; Hussain MA; Wasowska BA; Rabb H; Womer KL
Transplantation; 2010 Dec; 90(12):1307-11. PubMed ID: 21048532
[TBL] [Abstract][Full Text] [Related]
22. [Mesenchymal stem cells and the immune system--immunosuppression without drugs?].
Kiss J; Urbán VS; Dudics V; Vas V; Uher F
Orv Hetil; 2008 Feb; 149(8):339-46. PubMed ID: 18281229
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor-β-Expressing Mesenchymal Stem Cells Induce Local Tolerance in a Rat Liver Transplantation Model of Acute Rejection.
Tang J; Yang R; Lv L; Yao A; Pu L; Yin A; Li X; Yu Y; Nyberg SL; Wang X
Stem Cells; 2016 Nov; 34(11):2681-2692. PubMed ID: 27333806
[TBL] [Abstract][Full Text] [Related]
24. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial.
Tan J; Wu W; Xu X; Liao L; Zheng F; Messinger S; Sun X; Chen J; Yang S; Cai J; Gao X; Pileggi A; Ricordi C
JAMA; 2012 Mar; 307(11):1169-77. PubMed ID: 22436957
[TBL] [Abstract][Full Text] [Related]
25. Mesenchymal Stromal Cells in Solid Organ Transplantation.
Vandermeulen M; Erpicum P; Weekers L; Briquet A; Lechanteur C; Detry O; Beguin Y; Jouret F
Transplantation; 2020 May; 104(5):923-936. PubMed ID: 31929427
[TBL] [Abstract][Full Text] [Related]
26. The role of mesenchymal stromal cells in chronic transplant rejection after solid organ transplantation.
Reinders ME; Rabelink TJ; de Fijter JW
Curr Opin Organ Transplant; 2013 Feb; 18(1):44-50. PubMed ID: 23254697
[TBL] [Abstract][Full Text] [Related]
27. Understanding the Immunological Mechanisms of Mesenchymal Stem Cells in Allogeneic Transplantation: From the Aspect of Major Histocompatibility Complex Class I.
Wang Y; Tian M; Wang F; Heng BC; Zhou J; Cai Z; Liu H
Stem Cells Dev; 2019 Sep; 28(17):1141-1150. PubMed ID: 31215341
[TBL] [Abstract][Full Text] [Related]
28. Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study.
Pan GH; Chen Z; Xu L; Zhu JH; Xiang P; Ma JJ; Peng YW; Li GH; Chen XY; Fang JL; Guo YH; Zhang L; Liu LS
Oncotarget; 2016 Mar; 7(11):12089-101. PubMed ID: 26933811
[TBL] [Abstract][Full Text] [Related]
29. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
30. Potential of mesenchymal stem cells for the therapy of autoimmune diseases.
Pistoia V; Raffaghello L
Expert Rev Clin Immunol; 2010 Mar; 6(2):211-8. PubMed ID: 20402384
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cells as immunomodulators in a vascularized composite allotransplantation.
Kuo YR; Chen CC; Goto S; Lin PY; Wei FC; Chen CL
Clin Dev Immunol; 2012; 2012():854846. PubMed ID: 23227090
[TBL] [Abstract][Full Text] [Related]
32. Transplantation in 2011: New agents, new ideas and new hope.
Srinivas TR; Kaplan B
Nat Rev Nephrol; 2011 Dec; 8(2):74-5. PubMed ID: 22183507
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal stem cells overexpressing IL-35: a novel immunosuppressive strategy and therapeutic target for inducing transplant tolerance.
Guo H; Li B; Wang W; Zhao N; Gao H
Stem Cell Res Ther; 2018 Sep; 9(1):254. PubMed ID: 30257721
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.
Perico N; Casiraghi F; Gotti E; Introna M; Todeschini M; Cavinato RA; Capelli C; Rambaldi A; Cassis P; Rizzo P; Cortinovis M; Noris M; Remuzzi G
Transpl Int; 2013 Sep; 26(9):867-78. PubMed ID: 23738760
[TBL] [Abstract][Full Text] [Related]
35. Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study.
Reinders ME; Dreyer GJ; Bank JR; Roelofs H; Heidt S; Roelen DL; Zandvliet ML; Huurman VA; Fibbe WE; van Kooten C; Claas FH; Rabelink TJ; de Fijter JW
J Transl Med; 2015 Nov; 13():344. PubMed ID: 26537851
[TBL] [Abstract][Full Text] [Related]
36. Preliminary Study of Bone Marrow-Derived Mesenchymal Stem Cells Pretreatment With Erythropoietin in Preventing Acute Rejection After Rat Renal Transplantation.
Zhang Y; Zhou S; Hu JM; Chen H; Liu D; Li M; Guo Y; Fan LP; Li LY; Liu YG; Zhao M
Transplant Proc; 2018 Dec; 50(10):3873-3880. PubMed ID: 30577280
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal stem cells: a new strategy for immunosuppression?
Uccelli A; Pistoia V; Moretta L
Trends Immunol; 2007 May; 28(5):219-26. PubMed ID: 17400510
[TBL] [Abstract][Full Text] [Related]
38. Role of mesenchymal stem cells in immunological rejection of organ transplantation.
Zhang X; Jiao C; Zhao S
Stem Cell Rev Rep; 2009 Dec; 5(4):402-9. PubMed ID: 19543842
[TBL] [Abstract][Full Text] [Related]
39. Adipose-derived mesenchymal stem cells attenuate rejection in a rat lung transplantation model.
Watanabe H; Tsuchiya T; Shimoyama K; Shimizu A; Akita S; Yukawa H; Baba Y; Nagayasu T
J Surg Res; 2018 Jul; 227():17-27. PubMed ID: 29804850
[TBL] [Abstract][Full Text] [Related]
40. The Timing of Immunomodulation Induced by Mesenchymal Stromal Cells Determines the Outcome of the Graft in Experimental Renal Allotransplantation.
Merino A; Ripoll E; de Ramon L; Bolaños N; Goma M; Bestard O; Lloberas N; Grinyo JM; Ambròs JT
Cell Transplant; 2017 Jun; 26(6):1017-1030. PubMed ID: 28160460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
